AI evidence summary · MVP

Astaxanthin for Skin Health

AI preliminary evidence assessment

C

C 級|AI 整體初步評級

This preliminary assessment is currently available in Traditional Chinese.

Exact question對成人,口服單方蝦紅素或可分離的單方研究臂,相較安慰劑或其他照護相同的同期對照,是否改善皮膚水分含量、彈性、細紋或光曝反應,並有哪些不良反應?各終點與觀察時間分開,不泛化皮膚疾病治療。

已有三項單方口服、安慰劑對照研究,但皮膚指標的結果不一致。男性六週研究報告部分改善,卻缺少清楚的組間統計;女性十六週研究的全體組間比較未見差異,部分彈性改善只出現在次群。九週研究的紫外線反應變化量與特定照射條件下的水分結果有利,但絕對反應值、水分與經皮水分散失也有未顯著結果。小樣本、短期、多終點及企業關係限制判斷,目前不足以支持一般成人穩定改善所有皮膚指標,亦不能外推皮膚疾病治療。

Additional assessment reasons await presentation; see the research results below.

Limitations affecting this assessment
  • 直接證據規模小、追蹤僅6至16週,主要來自健康日本成人;不能泛化為皮膚疾病治療或長期光傷害預防。
  • PMID 22428137僅提供摘要,無法充分核對組間效應量、隨機化細節、不良反應及退出情形。
  • 28751807方法段為65人納入,結果段另稱59人納入臨床研究;兩段人數關係未清楚交代,不能據此確定59人完成或作最終分析。
  • 多終點、多時間點與小型分層分析增加偶然陽性可能;可見效果大小與臨床重要性仍不確定。
  • 本次中立口服配方PubMed查詢完整取得96筆候選;並非全球完整系統性回顧。原廣泛查詢245筆、上限150筆的不完整歷史保留。
  • 29941810為23名納入、22名分析;資金段稱無外部資助,同時利益衝突段稱FUJIFILM為贊助及資助者,三名作者任職該公司,兩項聲明均保留。28751807亦有企業資助。
  • 統合分析的水分與彈性合併結果有利,但皺紋深度未顯著;混方、活性比較、借用基線與插補標準差限制單方歸因,也不增加獨立試驗群體。
  • 讀者摘要選13項來源中的15筆模型事實;另24項背景未選入摘要。六項背景因必要欄位或數字角色未能完整驗證,保留來源卡但不生成有效讀者結果。
  • 機構立場資料多未對本題表態;部分謹慎立場是廣義皮膚補充品觀點,不是機構以蝦紅素試驗證明無效。
  • 本次外部證據資料庫資料缺失,系統性回顧也未被納入該計分欄位;兩個欄位各依原規則採0.5中性政策值。這些值不是研究支持票,也不表示文獻中沒有系統性回顧。
  • 三份直接報告依原文人群、性別、劑量、期間及可得方案支持三個不同試驗事件;不代表個人完全不重疊,不能加總為唯一受試者。
  • 22428137原摘要報告36名男性,但未明確交代人數流程類型;評分用人數欄位保持未知,並非原文沒有報告人數。另30名女性為口服加外用研究,不能合併成66名單方口服參與者。
  • 女性16週研究的全體樣本組間比較未顯著;安慰劑組內惡化而介入組未惡化,不等於已證明介入優於安慰劑。較高基線水分次群的彈性結果須另看。
  • 9週研究中,引起曬紅所需的最低紫外線劑量相對基線的變化有利,但介入後絕對值的組間差異未顯著;皮膚水分效益只見於較低照射強度(1.15倍最低致紅斑劑量)後第7天,較高強度(1.32倍)與經皮水分散失未顯著。
  • 短期未觀察到不良事件不能保證長期或罕見風險不存在;摘要未報告安全性時應保留未知。

Research results

Findings are currently provided in Traditional Chinese; source excerpts retain their original language.

Main result 1

6 週

6週男性研究報告魚尾紋、彈性及TEWL改善;臉頰水分與皮脂僅呈改善趨勢。摘要未提供效應量、信賴區間或清楚的組間統計,不能量化相較安慰劑的改善幅度。

Applicability assessment: 健康男性的口服蝦紅素安慰劑對照研究;同篇女性研究合併口服與外用且無對照,須分開解讀。

Population
健康男性
Intervention
每日口服蝦紅素6 mg
Comparator
安慰劑
Outcome
魚尾紋、皮膚彈性、經皮水分散失、臉頰水分及皮脂
Follow-up
6 週
Formulation
Not established
Dose
口服蝦紅素6 mg/日

No additional short excerpt is shown for this finding. See the linked source to check the result.

View source

Main result 2

16 週

全體樣本在第0、8、16週的各測量參數組間比較均未顯著。16週安慰劑組的深皺紋與水分較基線惡化,而蝦紅素組未顯著惡化,僅支持組內維持的描述。8週R2、R6在所有組別組內改善;16週僅6 mg組R6、R7組內改善。TEWL各組未變。較高基線水分次群中,12 mg組8週R2及R7優於安慰劑,分別p=0.001及0.002;6 mg組16週R7僅呈趨勢,p=0.100。次群結果不能替代全體結果;IL-1α屬機制指標。

Applicability assessment: 健康女性口服蝦紅素與安慰劑比較,測量皺紋、水分及彈性等皮膚指標。

Population
35至60歲、具有指定眼周皺紋程度的健康女性;納入65人
Intervention
每日口服蝦紅素6或12 mg
Comparator
含0 mg蝦紅素的安慰劑膠囊
Outcome
皺紋、皮膚水分、經皮水分散失及皮膚彈性
Follow-up
16 週
Formulation
Not established
Dose
口服蝦紅素6或12 mg/日

No additional short excerpt is shown for this finding. See the linked source to check the result.

View source

Main result 3

9 週

9週後MED絕對值為安慰劑44.0±6.2、蝦紅素48.4±8.2 mJ/cm2,組間p=0.162;相對基線的MED增加量則顯著優於安慰劑。1.15 MED照射後第7天水分下降較少;1.32 MED水分下降無組間差異,TEWL亦無顯著差異,未證實照射後第1天水分效益。非照射區粗糙皮膚及紋理主觀變化有利;魚尾紋、鼻唇溝、清晰度、年輕外觀及暗沉未顯著。

Applicability assessment: 健康成人口服蝦紅素與匹配安慰劑比較,評估實驗性紫外線照射後反應。

Population
健康日本成人;納入23人
Intervention
每日口服蝦紅素4 mg
Comparator
外形、味道及顏色不可區分的匹配安慰劑膠囊
Outcome
最小紅斑劑量
Follow-up
9 週
Formulation
Not established
Dose
口服蝦紅素4 mg/日,每日1粒
Source excerpt: However, the astaxanthin group showed a significant increase in MED from baseline compared with the placebo group after supplementation (Figure 2a,b).
View source

Additional finding 4

12週

12週後,組合補充品組的臉部皮膚彈性及經皮水分散失相較安慰劑有所改善。

Applicability assessment: 研究使用蝦紅素與膠原蛋白水解物的組合,無法單獨歸因於蝦紅素。

Population
中度光老化皮膚的健康受試者
Intervention
每日蝦紅素2 mg合併膠原蛋白水解物3 g
Comparator
安慰劑
Outcome
臉部皮膚彈性及經皮水分散失
Follow-up
12週
Formulation
Not established
Dose
Not established
Source excerpt: The supplement group showed significant improvements in skin elasticity and transepidermal water loss in photoaged facial skin after 12 weeks compared with the placebo group.
View source

Additional finding 5

8週

研究描述蝦紅素組的魚尾紋、皮膚水分及彈性有類似的組內改善。

Applicability assessment: 蝦紅素組與玫瑰果粉組作比較,屬活性對照。

Population
35至65歲、有魚尾紋的健康受試者
Intervention
口服蝦紅素
Comparator
玫瑰果粉
Outcome
臉部皺紋、皮膚水分及彈性
Follow-up
8週
Formulation
Not established
Dose
Not established
Source excerpt: A similar improvement was observed for astaxanthin, with P-values 0.05, 0.001, and 0.05.
View source

Safety finding 6

16 週

16週未報告嚴重不良事件,作者表示血液參數無異常變化;討論另稱12 mg/日未觀察到不良事件。部分血液指標有統計變化,但未被判定為異常。未提供逐組完整一般不良事件計數或詳細偵測流程,不能據此確立長期安全。

Applicability assessment: 同一項健康女性口服蝦紅素試驗的血液檢查及不良事件觀察。

Population
35至60歲、具有指定眼周皺紋程度的健康女性;納入65人
Intervention
每日口服蝦紅素6或12 mg
Comparator
含0 mg蝦紅素的安慰劑膠囊
Outcome
血液參數異常及嚴重不良事件
Follow-up
16 週
Formulation
Not established
Dose
口服蝦紅素6或12 mg/日
Source excerpt: There were no abnormal changes in blood parameters observed during the study period, and no serious adverse events were reported.
View source

Safety finding 7

9 週

作者報告未觀察到不良事件或血液檢查嚴重變化,亦未觀察到與攝取蝦紅素相關的不良事件。一名蝦紅素組參與者因補充前後膽紅素異常被排除分析,來源未證明該異常由介入造成;此排除仍需納入安全性與分析偏差考量。

Applicability assessment: 同一項健康成人口服蝦紅素試驗的不良事件與血液檢查觀察。

Population
健康日本成人;納入23人
Intervention
每日口服蝦紅素4 mg
Comparator
外形、味道及顏色不可區分的匹配安慰劑膠囊
Outcome
不良事件及血液生化、血液學檢查的嚴重變化
Follow-up
9 週
Formulation
Not established
Dose
口服蝦紅素4 mg/日,每日1粒

No additional short excerpt is shown for this finding. See the linked source to check the result.

View source

Additional finding 8

回顧的合併估計顯示水分及彈性結果有差異,皺紋深度的組間差異未達統計顯著;此為二次分析的結果。

Applicability assessment: 蝦紅素與人類皮膚老化的系統性回顧及統合分析,屬既有試驗的二次整理。

Population
人類研究受試者
Intervention
口服蝦紅素補充
Comparator
安慰劑
Outcome
皮膚水分、彈性及皺紋深度
Follow-up
Not established
Formulation
Not established
Dose
Not established

No additional short excerpt is shown for this finding. See the linked source to check the result.

View source

Additional finding 9

蝦紅素次群分析的角質層水分變化未達統計顯著。

Applicability assessment: 健康成人口服補充品與皮膚保濕的系統性回顧,包含蝦紅素次群分析。

Population
綜合研究;摘要未明確交代一致的人群條件
Intervention
蝦紅素補充
Comparator
安慰劑
Outcome
角質層水分含量
Follow-up
Not established
Formulation
Not established
Dose
Not established
Source excerpt: There was a non-significant improvement in the water content of stratum corneum for astaxanthin based on subgroup analyses.
View source

Sources consulted

  1. Cosmetic benefits of astaxanthin on humans subjects. Abstract only · 2026-10-06T12:57:50.500038Z
  2. Supplementating with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix metalloproteinase-1 and -12 expression: a comparative study with placebo. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  3. The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  4. Protective effects of astaxanthin on skin deterioration. Full text · 2026-10-06T12:57:50.500038Z
  5. Continuous astaxanthin intake reduces oxidative stress and reverses age-related morphological changes of residual skin surface components in middle-aged volunteers. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  6. The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People-A Randomized, Double-Blind, Placebo-Controlled Trial. Full text · 2026-10-06T12:57:50.500038Z
  7. Effects of Astaxanthin Supplementation on Skin Health: A Systematic Review of Clinical Studies. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  8. Role of ingestible carotenoids in skin protection: A review of clinical evidence. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  9. Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing. Context source; not counted as an included human-result report Full text · 2026-10-06T12:57:50.500038Z
  10. Effectiveness of Dietary Supplement for Skin Moisturizing in Healthy Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  11. A clinical evaluation of the efficacy and tolerability of a novel topical antioxidant formulation featuring vitamin C, astaxanthin, and fermented turmeric. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  12. Oral Supplements and Photoprotection: A Systematic Review. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z
  13. Effectiveness of dietary supplements for skin photoaging in healthy adults: a systematic review and meta-analysis of randomized controlled trials. Context source; not counted as an included human-result report Abstract only · 2026-10-06T12:57:50.500038Z

Reading and assessment notes

This is an AI preliminary assessment, not expert review or formal GRADE. Read the method and common limitations.

Absence of reported harms does not establish safety. This summary does not provide individual treatment or dosing advice.

Data and assessment record

Search coverage for this case

對成人,口服單方蝦紅素或可分離的單方研究臂,相較安慰劑或其他照護相同的同期對照,是否改善皮膚水分含量、彈性、細紋或光曝反應,並有哪些不良反應?各終點與觀察時間分開,不泛化皮膚疾病治療。

Searched:2026-10-06T12:57:50.500038Z · Databases:PubMed

96 records identified; 96 screened; 3 reports from 3 unique study populations included.

Some included reports were assessed without full text.

  • 部分候選文獻未取得全文,完整偏倚風險與次要結果評讀受限。
  • 系統檢索限於 PubMed;未涵蓋所有資料庫與完整引文追查。

Processing record

Evidence summary available

Sources through:2026-10-06 · Generated:2026-10-06T13:38:26.741431+00:00

Retrieved 96 records · Screened 96 · Included 3 reports · Omitted 93

Run:rating-candidate-final-v3

codex_cli / gpt-6.1-sol / problem-search-source-bound-l2+l11-v1

{
  "included": 3,
  "limits_hit": [
    "fulltext_unavailable",
    "limited_citation_tracing"
  ],
  "omitted": 93,
  "retrieved": 96,
  "screened": 96
}

sha256:9f1c303f984f48f760ab26dff44869416f1409f35ef114bd5ce53e9ba833a52f